Target intelligence / Profile preview

Rho-associated coiled-coil containing protein kinase 1 messenger RNA 3' untranslated region (ROCK1 mRNA 3'-UTR)

Target
ROCK1 mRNA 3'-UTR
Molecular classification
Messenger RNA (mRNA), Regulatory RNA element
01

Overview

The ROCK1 mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA encoding Rho-associated coiled-coil containing protein kinase 1. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that dictate the stability and translational efficiency of the ROCK1 transcript (Luo et al., 2011, PMID: 21602826). ROCK1 itself is a key downstream effector of the RhoA GTPase, playing a central role in actin cytoskeleton organization, cell adhesion, and motility (UniProt Q13464). Dysregulation of the ROCK1 mRNA 3'-UTR, often through the loss of inhibitory miRNA binding, leads to ROCK1 overexpression, which is a hallmark of metastatic progression in various cancers and contributes to cardiovascular and fibrotic diseases (Ueno et al., 2011, PMID: 21135154). Therapeutic strategies targeting this region involve the use of miRNA mimics or antisense oligonucleotides to suppress ROCK1 expression at the post-transcriptional level. These RNA-based approaches aim to reduce ROCK1 protein levels more selectively than traditional ATP-competitive kinase inhibitors, which often face challenges with isoform selectivity and systemic toxicity. Current research focuses on optimizing delivery systems to ensure these therapeutic agents reach target tissues effectively while minimizing off-target effects (Crooke et al., 2018, PMID: 29574378).

Other names
ROCK1 3'-UTRRho-associated protein kinase 1 mRNA 3'-UTRp160ROCK mRNA 3'-UTRRho-associated coiled-coil containing protein kinase 1 messenger RNA 3' untranslated region
02

Mechanism of action

Post-transcriptional gene silencing via RNA interference (RNAi) or antisense-mediated mRNA degradation, leading to reduced ROCK1 protein synthesis.

03

Biological functions

Post-transcriptional regulationmRNA stabilityTranslation regulationCell migrationCytoskeletal organization
04

Disease associations

CancerMetastasisCardiovascular diseaseGlaucomaFibrosis
05

Safety considerations

Off-target effects of RNA therapeuticsInnate immune response to oligonucleotidesSystemic hypotensionDelivery challenges to target tissues
06

Interacting drugs

miR-148a mimics

4 more in the full profile.

07

Biomarkers

ROCK1 protein expression levelsmiR-148a expressionmiR-584 expressionRhoA activity

Beyond the preview

Go deeper on Rho-associated coiled-coil containing protein kinase 1 messenger RNA 3' untranslated region (ROCK1 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho-associated coiled-coil containing protein kinase 1 messenger RNA 3' untranslated region (ROCK1 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call